Terbinafine Hydrochloride Cream
Product Images NDC 68788-9814

3 FDA label images from Preferred Pharmaceuticals, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Terbinafine Hydrochloride (NDC 68788-9814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Terbinafine 01)

Figure 1 (Terbinafine 01)
An anatomical illustration showing a close-up view of toes, with crosshair markers targeting five different areas on four toes. The image likely relates to the topical application or treatment targeting these specific toe areas.*
FDA Label Image

Figure 2 (Terbinafine 02)

Figure 2 (Terbinafine 02)
An instructional diagram showing a human foot, with focus on the toe and ankle areas, featuring target marks on the big toe and the outer ankle. This illustration likely relates to application or treatment areas for a topical medication.*
FDA Label Image

Terbinafine Hydrochloride Cream 1 Percent Label (Terbinafine 03)

Terbinafine Hydrochloride Cream 1 Percent Label (Terbinafine 03)
Terbinafine Hydrochloride Cream 1% topical cream label by Preferred Pharmaceuticals, Inc. The label shows the product as a generic for Lamisil Cream with Terbinafine hydrochloride 1% active ingredient. It includes instructions for external use, dose directions in English and Spanish, and warnings. Manufacturer is listed as Taro Pharmaceuticals, Hawthorne, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.